Add BrightSurf on Google Email

Uncovering the shield: gene duplication behind antifungal resistance in Madurella fahalii

Researchers discovered that a specific gene duplication in the fungus Madurella fahalii enables it to neutralize medication, leading to effective treatment challenges. This study highlights the potential of molecular techniques to uncover drug resistance mechanisms and pave the way for targeted therapies.

SourceChiba University·JournalPLOS Neglected Tropical Diseases·TypeExperimental study·DateMay 22, 2025

RSV infections in children requiring primary care lead to significant economic impact

Infections from respiratory syncytial virus (RSV) in children requiring primary care led to significant societal economic costs. The study found that the main sources of costs were repeated visits to primary care physicians and parents missing work to care for their sick children, with higher costs for infants under 1 year old.

SourceEuropean Centre for Disease Prevention and Control (ECDC)·JournalEurosurveillance·TypeObservational study·DateMay 22, 2025

First all-oral treatment for a rare but deadly strain of sleeping sickness now available and being used to treat patients in endemic countries in Africa

A breakthrough all-oral treatment for a rare but deadly strain of sleeping sickness is now available, revolutionizing care for patients in endemic countries. Fexinidazole Winthrop has been approved for use in several African countries and is being distributed by WHO, offering a safer alternative to existing treatments.

Excess weight, including overweight and obesity, is linked with experiencing Long COVID neurological symptoms including headaches, vertigo, sleep problems and depression, per meta-analysis of studies comprising almost 140,000 total participants

A meta-analysis of over 140,000 participants found a significant association between excess weight and neurological/neuropsychiatric symptoms in post-COVID-19 condition. The study suggests that maintaining a healthy weight may be crucial in mitigating these symptoms.

SourcePLOS·JournalPLOS One·DateMay 7, 2025

New study highlights mental health challenges among Ecuadorian healthcare providers during COVID-19

A recent study revealed critical insights into the mental health of healthcare providers in Ecuador during the COVID-19 pandemic. Key findings include high compassion satisfaction, moderate burnout, and moderate secondary traumatic stress, with significant differences based on gender, professional roles, and geographic regions.

SourceSociety for Disaster Medicine and Public Health, Inc.·JournalDisaster Medicine and Public Health Preparedness·TypeSurvey·DateMay 5, 2025

New molecular label could lead to simpler, faster tuberculosis tests

Researchers have developed a method to label and visualize the glycans in Mycobacterium tuberculosis cells, which may lead to faster and cheaper diagnostic tests for TB. The approach uses an organic molecule that reacts with specific sulfur-containing sugars found in only three bacterial species, including M. tuberculosis.

SourceMassachusetts Institute of Technology·JournalProceedings of the National Academy of Sciences·DateMay 5, 2025

Singapore scientists unveil one of world’s largest long-read RNA sequencing datasets to advance disease research

A team of Singaporean scientists has released a comprehensive long-read RNA sequencing dataset, SG-NEx, to accelerate biomarker discovery and precision medicine. The dataset offers deeper biological insights into RNA complexity, enabling researchers to detect clinically relevant biomarkers and develop better treatments.

New research lays groundwork for early detection of Alzheimer’s disease

A new study from Columbia University Mailman School of Public Health found significant associations between cognition and established risk factors for Alzheimer's disease in individuals aged 24-44. The researchers used biomarkers related to cognitive impairment and cardiovascular health to predict long-term trajectories of cognitive de...

Pediatric investigation publishes China’s first clinical guidelines for juvenile-onset recurrent respiratory papillomatosis

Juvenile-onset recurrent respiratory papillomatosis (JORRP) is a rare disease causing chronic hoarseness and breathing difficulties in children. New clinical guidelines provide actionable recommendations for early recognition, diagnosis, and treatment to improve long-term outcomes.

SourcePediatric Investigation·JournalPediatric Investigation·TypeSystematic review·DateApr 21, 2025

Colder temperatures increase gastroenteritis risk in Rohingya refugee camps

A new study by Hokkaido University found that colder temperatures significantly increase the risk of gastroenteritis among Rohingya refugees in Bangladesh's Kutupalong and Nayapara camps. The study reveals a link between temperature changes and gastroenteritis risk, with both extreme cold and heat contributing to higher numbers of cases.

SourceHokkaido University·JournalJAMA Network Open·TypeData/statistical analysis·DateApr 18, 2025

A new smartphone-sized device can test for tuberculosis. Here’s why that matters for children

Tulane University scientists developed a handheld device to deliver rapid and accurate tuberculosis diagnoses in under an hour. The device, called the lab-in-tube assay (LIT), can detect Mycobacterium tuberculosis DNA in saliva, blood, and sputum samples, offering a cost-effective tool for improving TB diagnoses in resource-limited areas.

SourceTulane University·JournalScience Translational Medicine·DateApr 9, 2025

Scientists assemble worlds first immune cell atlas from diverse Asian populations

Researchers have created the world's first Asian Immune Diversity Atlas, profiling healthy immune systems of diverse Asian populations. The study identified unique molecular properties and refined biomarkers for diagnosing diseases, which could help develop targeted therapies tailored to Asian patients.

SourceAgency for Science, Technology and Research (A*STAR), Singapore·JournalCell·TypeRandomized controlled/clinical trial·DateApr 7, 2025

How Zika virus knocks out our immune defenses

Researchers from La Jolla Institute for Immunology and UC San Diego discover Zika virus blocks dendritic cells' ability to alert T cells, while dengue virus stimulates pro-inflammatory cytokines, leading to a stronger but uncontrolled immune response. Understanding these differences is key to developing life-saving vaccines.

SourceLa Jolla Institute for Immunology·JournalNature Communications·TypeExperimental study·DateMar 25, 2025

New study by Korea University researchers reveals a safer alternative for long-term hepatitis B treatment

A new study by Korea University researchers reveals that switching to besifovir may improve patient kidney and bone health for long-term hepatitis B treatment. The study showed that patients who switched to besifovir had higher estimated glomerular filtration rate indicating improved kidney function and higher hip and spine bone densit...

SourceKorea University College of Medicine·JournalClinical and Molecular Hepatology·TypeRandomized controlled/clinical trial·DateMar 24, 2025

Meningococcal vaccine found to be safe and effective for infants in sub-Saharan Africa

A new study has provided evidence for the safety and effectiveness of a meningococcal pentavalent vaccine in young children beginning at 9 months of age in sub-Saharan Africa. The vaccine protects against five strains of meningitis prevalent in the region, and its use could lead to a significant reduction in meningitis cases and deaths.

SourceUniversity of Maryland School of Medicine·JournalThe Lancet·TypeRandomized controlled/clinical trial·DateMar 11, 2025

Research identifies key antibodies for development of broadly protective norovirus vaccine

Researchers have identified powerful antibodies capable of neutralizing a wide range of norovirus strains, paving the way for designing a broadly effective norovirus vaccine. The discovery brings us closer to a vaccine that could provide lasting protection and prevent devastating effects of norovirus outbreaks.

SourceUniversity of Texas at Austin·JournalScience Translational Medicine·TypeExperimental study·DateMar 5, 2025

Children’s Hospital of Philadelphia researchers use a “Trojan Horse” approach to develop new antimalarial drugs

Children's Hospital of Philadelphia researchers have discovered a key process where malarial parasites take up human blood cell enzymes, which could provide a new approach for antimalarial treatment. The findings suggest that a human enzyme, acylpeptide hydrolase (APEH), is the major activating enzyme of multiple antimalarial prodrugs.

SourceChildren's Hospital of Philadelphia·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateMar 5, 2025